Michael Rosenzweig
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Hematology 38
- Multiple Myeloma Research and Treatments 29
- Hematopoietic Stem Cell Transplantation 12
- Virology 15
- HIV Research and Treatment 15
- Co-authors
- R. Paul JohnsonRonald C. DesrosiersMaryAnn DeMariaAndrew A. LacknerRonald S. VeazeyLaura V. ChalifouxDouglas R. PauleyHeather Knight
- Journals
- Blood (21 papers)Journal of Virology (7 papers)Journal of Clinical Oncology (3 papers)Bone Marrow Transplantation (3 papers)Immunology (2 papers)
- Partner nations
- United StatesUnited KingdomGreece
In The Last Decade
Michael Rosenzweig
93 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Virology 1.9k
- Immunology 2.0k
- Hematology 962
- Genetics 746
- Infectious Diseases 881
Countries citing papers authored by Michael Rosenzweig
This map shows the geographic impact of Michael Rosenzweig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rosenzweig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rosenzweig more than expected).
Fields of papers citing papers by Michael Rosenzweig
This network shows the impact of papers produced by Michael Rosenzweig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rosenzweig. The network helps show where Michael Rosenzweig may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Rosenzweig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 0 | |
| 3 | 2021 | 70 | |
| 4 | 2020 | 51 | |
| 5 | Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors | 2020 | 0 |
| 6 | 2020 | 80 | |
| 7 | 2020 | 6 | |
| 8 | 2017 | 2 | |
| 9 | 2017 | 0 | |
| 10 | 2012 | 7 | |
| 11 | 2010 | 24 | |
| 12 | 2009 | 2 | |
| 13 | 2003 | 13 | |
| 14 | 2001 | 2 | |
| 15 | 2000 | 35 | |
| 16 | 2000 | 71 | |
| 17 | 1999 | 30 | |
| 18 | 1998 | 155 | |
| 19 | 1997 | 3 | |
| 20 | 1993 | 110 |
About Michael Rosenzweig
Michael Rosenzweig is a scholar working on Hematology, Virology, Immunology, Genetics and Oncology, having authored 99 papers that have together received 5.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (29 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (24 papers), Immune Cell Function and Interaction (20 papers), HIV Research and Treatment (15 papers), Hematopoietic Stem Cell Transplantation (12 papers), T-cell and B-cell Immunology (11 papers), Immunotherapy and Immune Responses (9 papers) and Peptidase Inhibition and Analysis (8 papers). The work is most often cited by research in Virology (1.9k citations), Immunology (2.0k citations), Hematology (962 citations), Genetics (746 citations) and Infectious Diseases (881 citations). Michael Rosenzweig has collaborated with scholars based in United States, United Kingdom and Greece. Frequent co-authors include R. Paul Johnson, Ronald C. Desrosiers, MaryAnn DeMaria, Andrew A. Lackner, Ronald S. Veazey, Laura V. Chalifoux, Douglas R. Pauley, Heather Knight, Douglas Marks and R. Paul Johnson. Their work appears in journals such as Blood, Journal of Virology, Journal of Clinical Oncology, Bone Marrow Transplantation and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.